Allworth Financial’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Allworth Financial’s Portfolio IRLA Stock Details IRLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$137	Buy	+8	New	+$184	﹤0.01%	5000
2026 Q1	–	Sell	-8	Closed	-$5.03K	–	5294
2025 Q4	$5.03K	Buy	+8	New	+$4.03K	﹤0.01%	3709
2023 Q4	–	Sell	-1	Closed	-$300	–	3586
2023 Q3	$300	Hold	1	–	–	﹤0.01%	3169
2023 Q2	$402	Hold	1	–	–	﹤0.01%	2936
2023 Q1	$417	Buy	+1	New	+$196	﹤0.01%	2877

Other funds holding IRLA

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Allworth Financial's IRLA Position: Q2 2026 in Review

Allworth Financial opened a new position in IRulya Therapeutics Inc. Common Stock (IRLA) in Q2 2026: 8 shares worth $137. The stake represents ﹤0.01% of the portfolio and ranks #5000 among its holdings. This is a return to the name: Allworth Financial previously reported a position in IRLA as recently as Q4 2025.

Allworth Financial first reported a position in IRLA in Q1 2023 and has held it in 5 quarters since. The position peaked at $5.03K in Q4 2025. 26 funds tracked by Wall St. Rank hold IRLA as of Q2 2026.

Allworth Financial held 8 shares of IRulya Therapeutics Inc. Common Stock worth $137 as of Q2 2026.
IRulya Therapeutics Inc. Common Stock was a new Allworth Financial position in Q2 2026.
IRulya Therapeutics Inc. Common Stock made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #5000 holding.
Allworth Financial first reported a position in IRulya Therapeutics Inc. Common Stock in Q1 2023 and has held it in 5 quarters since.
Allworth Financial's IRulya Therapeutics Inc. Common Stock position peaked at $5.03K in Q4 2025.
26 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.